251 related articles for article (PubMed ID: 23288416)
1. Long-term use of aspirin and age-related macular degeneration.
Klein BE; Howard KP; Gangnon RE; Dreyer JO; Lee KE; Klein R
JAMA; 2012 Dec; 308(23):2469-78. PubMed ID: 23288416
[TBL] [Abstract][Full Text] [Related]
2. The association of aspirin use with age-related macular degeneration.
Liew G; Mitchell P; Wong TY; Rochtchina E; Wang JJ
JAMA Intern Med; 2013 Feb; 173(4):258-64. PubMed ID: 23337937
[TBL] [Abstract][Full Text] [Related]
3. Vasodilators, blood pressure-lowering medications, and age-related macular degeneration: the Beaver Dam Eye Study.
Klein R; Myers CE; Klein BE
Ophthalmology; 2014 Aug; 121(8):1604-11. PubMed ID: 24793737
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for incident age-related macular degeneration: pooled findings from 3 continents.
Tomany SC; Wang JJ; Van Leeuwen R; Klein R; Mitchell P; Vingerling JR; Klein BE; Smith W; De Jong PT
Ophthalmology; 2004 Jul; 111(7):1280-7. PubMed ID: 15234127
[TBL] [Abstract][Full Text] [Related]
5. Severity of age-related macular degeneration in 1 eye and the incidence and progression of age-related macular degeneration in the fellow eye: the Beaver Dam Eye Study.
Gangnon RE; Lee KE; Klein BE; Iyengar SK; Sivakumaran TA; Klein R
JAMA Ophthalmol; 2015 Feb; 133(2):125-32. PubMed ID: 25340497
[TBL] [Abstract][Full Text] [Related]
6. Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study.
Klein R; Klein BE; Knudtson MD; Meuer SM; Swift M; Gangnon RE
Ophthalmology; 2007 Feb; 114(2):253-62. PubMed ID: 17270675
[TBL] [Abstract][Full Text] [Related]
7. Incidence of and Risk Factors Associated With Age-Related Macular Degeneration: Four-Year Follow-up From the ALIENOR Study.
Saunier V; Merle BMJ; Delyfer MN; Cougnard-Grégoire A; Rougier MB; Amouyel P; Lambert JC; Dartigues JF; Korobelnik JF; Delcourt C
JAMA Ophthalmol; 2018 May; 136(5):473-481. PubMed ID: 29596588
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Regular Use of Low-Dose Aspirin and Neovascular Age-Related Macular Degeneration: National Sample Cohort 2010-2015.
Rim TH; Yoo TK; Kwak J; Lee JS; Kim SH; Kim DW; Kim SS
Ophthalmology; 2019 Feb; 126(2):274-282. PubMed ID: 30240791
[TBL] [Abstract][Full Text] [Related]
9. Generational Differences in the 5-Year Incidence of Age-Related Macular Degeneration.
Cruickshanks KJ; Nondahl DM; Johnson LJ; Dalton DS; Fisher ME; Huang GH; Klein BE; Klein R; Schubert CR
JAMA Ophthalmol; 2017 Dec; 135(12):1417-1423. PubMed ID: 29145549
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular risk factors and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study.
Tan JS; Mitchell P; Smith W; Wang JJ
Ophthalmology; 2007 Jun; 114(6):1143-50. PubMed ID: 17275090
[TBL] [Abstract][Full Text] [Related]
11. The relationship of atherosclerosis to the 10-year cumulative incidence of age-related macular degeneration: the Beaver Dam studies.
Klein R; Cruickshanks KJ; Myers CE; Sivakumaran TA; Iyengar SK; Meuer SM; Schubert CR; Gangnon RE; Klein BE
Ophthalmology; 2013 May; 120(5):1012-9. PubMed ID: 23399375
[TBL] [Abstract][Full Text] [Related]
12. The Association of Aspirin Use with Age-Related Macular Degeneration Progression in the Age-Related Eye Disease Studies: Age-Related Eye Disease Study 2 Report No. 20.
Keenan TD; Wiley HE; Agrón E; Aronow ME; Christen WG; Clemons TE; Chew EY;
Ophthalmology; 2019 Dec; 126(12):1647-1656. PubMed ID: 31358390
[TBL] [Abstract][Full Text] [Related]
13. Age-period-cohort effect on the incidence of age-related macular degeneration: the Beaver Dam Eye Study.
Klein R; Knudtson MD; Lee KE; Gangnon RE; Klein BE
Ophthalmology; 2008 Sep; 115(9):1460-7. PubMed ID: 18762073
[TBL] [Abstract][Full Text] [Related]
14. Markers of inflammation, oxidative stress, and endothelial dysfunction and the 20-year cumulative incidence of early age-related macular degeneration: the Beaver Dam Eye Study.
Klein R; Myers CE; Cruickshanks KJ; Gangnon RE; Danforth LG; Sivakumaran TA; Iyengar SK; Tsai MY; Klein BE
JAMA Ophthalmol; 2014 Apr; 132(4):446-55. PubMed ID: 24481424
[TBL] [Abstract][Full Text] [Related]
15. Oxidized Low-density Lipoprotein and the Incidence of Age-related Macular Degeneration.
Klein R; Lee KE; Tsai MY; Cruickshanks KJ; Gangnon RE; Klein BEK
Ophthalmology; 2019 May; 126(5):752-758. PubMed ID: 30572074
[TBL] [Abstract][Full Text] [Related]
16. Cigarette smoking and the natural history of age-related macular degeneration: the Beaver Dam Eye Study.
Myers CE; Klein BE; Gangnon R; Sivakumaran TA; Iyengar SK; Klein R
Ophthalmology; 2014 Oct; 121(10):1949-55. PubMed ID: 24953792
[TBL] [Abstract][Full Text] [Related]
17. Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study.
Klein R; Klein BE; Tomany SC; Meuer SM; Huang GH
Ophthalmology; 2002 Oct; 109(10):1767-79. PubMed ID: 12359593
[TBL] [Abstract][Full Text] [Related]
18. Physical activity and the 15-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study.
Knudtson MD; Klein R; Klein BE
Br J Ophthalmol; 2006 Dec; 90(12):1461-3. PubMed ID: 17077116
[TBL] [Abstract][Full Text] [Related]
19. The Incidence and Progression of Age-Related Macular Degeneration over 15 Years: The Blue Mountains Eye Study.
Joachim N; Mitchell P; Burlutsky G; Kifley A; Wang JJ
Ophthalmology; 2015 Dec; 122(12):2482-9. PubMed ID: 26383995
[TBL] [Abstract][Full Text] [Related]
20. The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam Eye Study.
Klein R; Klein BE; Tomany SC; Cruickshanks KJ
Ophthalmology; 2003 Jun; 110(6):1273-80. PubMed ID: 12799274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]